FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:40-44 January 3, 2002 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.

A healthy 50-year-old woman at average risk for colorectal cancer (i.e., age is her only risk factor) is scheduled to undergo a periodic examination. Which screening test for colorectal cancer should be recommended?

The Clinical Problem

Even though colorectal cancer is the second most common cause of cancer-related death in the United States¹ and screening can reduce the rate of death by detecting early cancer . . . [Full Text of this Article]

Strategies and Evidence

Fecal Occult-Blood Testing

Sigmoidoscopy

Colonoscopy

Other Tests

Comparison of Different Tests

Areas of Uncertainty

Guidelines

Conclusions and Recommendations

Source Information

From the Departments of Medicine and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill.

Address reprint requests to Dr. Ransohoff at CB 7080, 724 Burnett-Womack Bldg., University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7080, or at ransohof@med.unc.edu.

References

Related Letters:

Screening for Colorectal Cancer
Maule W. F., Bruzzi J. F., Brennan D. D., Fenlon H. M., Sood A., Sood R., Ransohoff D. F., Sandler R. S.
Extract | Full Text | PDF  
N Engl J Med 2002; 346:1672-1674, May 23, 2002. Correspondence

This article has been cited by other articles:

• Schneider, E. C., Nadel, M. R., Zaslavsky, A. M., McGlynn, E. A. (2008). Assessment of the Scientific Soundness of Clinical Performance Measures: A Field Test of the National Committee for Quality Assurance's Colorectal Cancer Screening Measure. Arch Intern Med 168: 876-882 [Abstract] [Full Text]  
• Chen, S., Wang, W., Lee, S., Nafa, K., Lee, J., Romans, K., Watson, P., Gruber, S. B., Euhus, D., Kinzler, K. W., Jass, J., Gallinger, S., Lindor, N. M., Casey, G., Ellis, N., Giardiello, F. M., Offit, K., Parmigiani, G., for the Colon Cancer Family Registry, (2006). Prediction of germline mutations and cancer risk in the Lynch syndrome.. JAMA 296: 1479-1487 [Abstract] [Full Text]  
• Taylor, W. C. (2006). A 71-Year-Old Woman Contemplating a Screening Colonoscopy. JAMA 295: 1161-1167 [Full Text]  
• Kim, H., Kim, Y., Yoon, S., Lim, J., Kim, M., Lee, S., Kang, S., Lee, E. J., Kang, C. S., Han, K. (2006). Rapid Fecal Cytokeratin-19 Test and Fecal Occult Blood Test in Screening for Gastrointestinal Diseases. Annals of Clinical & Laboratory Science 36: 294-298 [Abstract] [Full Text]  
• Fisher, J. A., Fikry, C., Troxel, A. B. (2006). Cutting Cost and Increasing Access to Colorectal Cancer Screening: Another Approach to Following the Guidelines. Cancer Epidemiol. Biomarkers Prev. 15: 108-113 [Abstract] [Full Text]  
• Macari, M., Bini, E. J. (2005). CT Colonography: Where Have We Been and Where Are We Going?. Radiology 237: 819-833 [Abstract] [Full Text]  
• Aldous, M. B. (2005). The Cost of Saving 6 Million Children's Lives. AAP Grand Rounds 14: 52-53 [Full Text]  
• Kinney, A. Y., Bloor, L. E., Martin, C., Sandler, R. S. (2005). Social Ties and Colorectal Cancer Screening among Blacks and Whites in North Carolina. Cancer Epidemiol. Biomarkers Prev. 14: 182-189 [Abstract] [Full Text]  
• Patnick, J., Ransohoff, D., Atkin, W., Ma Borras, J., Elwood, M., Hoff, G., Nadel, M., Russo, A., Simon, J., Weiderpass-Vaino, E., Zappa, M., Smith, R. (2005). Workgroup III: facilitating screening for colorectal cancer: quality assurance and evaluation. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). Ann Oncol 16: 34-37 [Full Text]  
• Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Turnbull, B. A., Ross, M. E., the Colorectal Cancer Study Group, (2004). Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk Population. NEJM 351: 2704-2714 [Abstract] [Full Text]  
• Khoury, M. J, Millikan, R., Little, J., Gwinn, M. (2004). The emergence of epidemiology in the genomics age. Int J Epidemiol 33: 936-944 [Full Text]  
• Macari, M., Bini, E. J., Jacobs, S. L., Naik, S., Lui, Y. W., Milano, A., Rajapaksa, R., Megibow, A. J., Babb, J. (2004). Colorectal Polyps and Cancers in Asymptomatic Average-Risk Patients: Evaluation with CT Colonography. Radiology 230: 629-636 [Abstract] [Full Text]  
• Hawley, S. T., Vernon, S. W., Levin, B., Vallejo, B. (2004). Prevalence of Colorectal Cancer Screening in a Large Medical Organization. Cancer Epidemiol. Biomarkers Prev. 13: 314-319 [Abstract] [Full Text]  
• Imperiale, T. F., Wagner, D. R., Lin, C. Y., Larkin, G. N., Rogge, J. D., Ransohoff, D. F. (2003). Using Risk for Advanced Proximal Colonic Neoplasia To Tailor Endoscopic Screening for Colorectal Cancer. ANN INTERN MED 139: 959-965 [Abstract] [Full Text]  
• Morrin, M. M., LaMont, J. T. (2003). Screening Virtual Colonoscopy -- Ready for Prime Time?. NEJM 349: 2261-2264 [Full Text]  
• Ferrucci, J. T. (2003). Virtual Colonoscopy for Colon Cancer Screening: Further Reflections on Polyps and Politics. Am. J. Roentgenol. 181: 795-797 [Full Text]  
• Ferenci, P (2003). How to identify the genetic basis of gastrointestinal and liver diseases?. Gut 52: ii6-9 [Abstract] [Full Text]  
• Sirovich, B. E., Schwartz, L. M., Woloshin, S. (2003). Screening Men for Prostate and Colorectal Cancer in the United States: Does Practice Reflect the Evidence?. JAMA 289: 1414-1420 [Abstract] [Full Text]  
• Watson, A J M (2003). Are proximal colorectal cancers always associated with distal adenomas?. Gut 52: 317-318 [Full Text]  
• Macafee, D A L, Scholefield, J H (2003). Population based endoscopic screening for colorectal cancer. Gut 52: 323-326 [Full Text]  
• Khoury, M. J., McCabe, L. L., McCabe, E. R.B. (2003). Population Screening in the Age of Genomic Medicine. NEJM 348: 50-58 [Full Text]  
• Kim, Y., Lee, S., Park, S., Jeon, H., Lee, W., Kim, J. K., Cho, M., Kim, M., Lim, J., Kang, C. S., Han, K. (2003). Gastrointestinal Tract Cancer Screening Using Fecal Carcinoembryonic Antigen. Annals of Clinical & Laboratory Science 33: 32-38 [Abstract] [Full Text]  
• Scholefield, J. H (2002). Screening for colorectal cancer. Br Med Bull 64: 75-80 [Abstract] [Full Text]  
• Ransohoff, D. F., Traverso, G., Kinzler, K. W., Vogelstein, B. (2002). Fecal DNA Tests for Colorectal Cancer. NEJM 346: 1912-1913 [Full Text]  
• Maule, W. F., Bruzzi, J. F., Brennan, D. D., Fenlon, H. M., Sood, A., Sood, R., Ransohoff, D. F., Sandler, R. S. (2002). Screening for Colorectal Cancer. NEJM 346: 1672-1674 [Full Text]